scholarly article | Q13442814 |
P356 | DOI | 10.1177/0269881108098820 |
P698 | PubMed publication ID | 19010974 |
P50 | author | Guy M. Goodwin | Q5622285 |
Richard Gray | Q37830030 | ||
David Taylor | Q55762444 | ||
P2093 | author name string | B Moore | |
M Taylor | |||
K J Aitchison | |||
P M Haddad | |||
G Sullivan | |||
J Cookson | |||
L Ratna | |||
M Bienroth | |||
P2860 | cites work | Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review | Q33988376 |
Pharmacokinetics of aripiprazole and concomitant lithium and valproate | Q34376865 | ||
Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability | Q34548876 | ||
Adverse effects of atypical antipsychotics : differential risk and clinical implications | Q34583643 | ||
Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology | Q35180787 | ||
Guidelines for maintenance treatment of bipolar disorder: are there discrepancies between European and North American recommendations? | Q35947331 | ||
Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications | Q36216515 | ||
Abnormal glucose metabolism in patients treated with antipsychotics | Q36782498 | ||
Medical comorbidity in bipolar disorder: re-prioritizing unmet needs | Q36841349 | ||
The expert consensus guideline series. Treatment of behavioral emergencies 2005. | Q40368586 | ||
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 | ||
Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 | ||
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial | Q44915194 | ||
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol | Q45168624 | ||
Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine | Q46549460 | ||
Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial | Q46596821 | ||
Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study | Q46669710 | ||
Risperidone in the treatment of acute mania: double-blind, placebo-controlled study | Q46681460 | ||
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial | Q46681464 | ||
Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial | Q46683979 | ||
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 | ||
Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder | Q46975571 | ||
Discovering the neural basis of human social anxiety: a diagnostic and therapeutic imperative | Q48102710 | ||
Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance | Q48380306 | ||
Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel | Q48464094 | ||
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole | Q48472617 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 10 | |
P304 | page(s) | 231-240 | |
P577 | publication date | 2008-11-14 | |
P1433 | published in | Journal of Psychopharmacology | Q6295819 |
P1476 | title | A UK consensus on the administration of aripiprazole for the treatment of mania | |
P478 | volume | 23 |